Naturally Splendid is in the process of an internal review of the significant cannabinoid-based research and development, purchased within the Boreal transaction. Regulations in Canada, and the reluctance of the TSX to support cannabinoid-based opportunities in USA, have slowed commercialization of these technologies. However, with the recent application of the Processors License, and expected revised hemp and marijuana regulations in Canada in 2018, these technologies and by extension opportunities, will be methodically vetted by the Company.